Clinical Trial Update: Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING) [Phase 4]

View source ↗

Summary

Phase 4 trial update on using genetic markers to guide pharmacological treatment for smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Smoking Cessation, Genetic Predisposition | Phase 4 | Status: COMPLETED